Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 2.2 EX-2.2
- 4.19 EX-4.19
- 5.1 EX-5.1
- 8.1 EX-8.1
- 8.2 EX-8.2
- 10.48 EX-10.48
- 10.49 EX-10.49
- 21.1 EX-21.1
- 23.3 EX-23.3
- 23.4 EX-23.4
- 23.5 EX-23.5
- 24.2 EX-24.2
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- Download Excel data file
- View Excel data file
Associated filings
- 24 Mar 21 EFFECT Notice of effectiveness
- 23 Mar 21 424B3 Prospectus supplement
-
19 Mar 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Jan 21 S-4 Registration of securities issued in business combination transactions
TNFA similar filings
Filing view
External links
Exhibit 23.5
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion of our Auditors’ Report dated February 23, 2021, on the financial statements of Supera Pharmaceuticals, Inc. as of and for the years ended December 31, 2020 and 2019 in this Registration Statement on Form S-4. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Cherry Bekaert LLP
Tampa, Florida
March 19, 2021